Should a patient on insulin glargine (Lantus) 15 units twice daily hold the dose if blood glucose is low?

Basal Insulin Should NOT Be Held for Low Blood Glucose

Do not hold scheduled basal insulin (Lantus) based on a single low blood glucose reading. Basal insulin provides continuous background insulin coverage independent of meals and should be continued even when blood glucose is low, with appropriate treatment of the hypoglycemia itself 1.

Key Management Principles

Basal Insulin Continuation

• Lantus (insulin glargine) provides 24-hour basal coverage and should be administered at the same time daily regardless of current blood glucose levels 1
• The FDA label explicitly warns that the "prolonged effect of subcutaneous LANTUS may delay recovery from hypoglycemia," but this refers to treatment of hypoglycemia episodes, not a reason to hold the dose 1
• Basal insulin is fundamentally different from meal-time (bolus) insulin—it maintains baseline glucose control between meals and overnight

What Should Actually Be Held

Hold or adjust prandial (mealtime) insulin, not basal insulin:

• Rapid-acting insulin before meals should be held if the patient is NPO (nothing by mouth) or unable to eat 2
• Current guidelines recommend: "Give basal insulin once (glargine/detemir) or twice (detemir/NPH) daily, at the same time each day. Give rapid-acting (prandial) insulin in three equally divided doses before each meal. Hold prandial insulin if patient is not able to eat" 2

Hypoglycemia Management Protocol

When blood glucose is low (defined as <70 mg/dL or <3.9 mmol/L):

1. Treat the hypoglycemia immediately with 15-20 grams of glucose or carbohydrate 3, 4
2. Continue the scheduled basal insulin as ordered
3. Reassess the insulin regimen if hypoglycemia recurs 4

The 2023 ADA Standards recommend: "One or more episodes of level 2 or 3 hypoglycemia should prompt reevaluation of the treatment plan, including deintensifying or switching diabetes medications if appropriate" 4. This means adjusting future doses, not holding the current scheduled basal dose.

Clinical Context for Hospitalized Patients

Dose Reduction Scenarios

The 2012 Endocrine Society guidelines specify when basal insulin doses should be reduced (not held):

• 0.2 to 0.3 U/kg for patients aged ≥70 years and/or GFR <60 mL/min 2
• 20% reduction when transitioning from twice-daily NPH to once-daily Lantus 5, 1
• Patients with renal or hepatic impairment may require dose reduction due to prolonged hypoglycemia risk 1

NPO or Fasting Patients

For patients who are NPO or have poor oral intake:

• Continue basal insulin (glargine once daily or NPH twice daily)
• Hold prandial insulin until nutrition is resumed
• Administer correction insulin every 4-6 hours for hyperglycemia as needed 2

Common Pitfalls to Avoid

1. Do not confuse basal and bolus insulin management: The most common error is applying meal-time insulin logic to basal insulin. Basal insulin maintains baseline glucose control and should not be held for low readings.

2. Do not use "sliding scale only" approaches: Using only correctional insulin without scheduled basal insulin is explicitly discouraged in guidelines and leads to poor glycemic control 6, 2

3. Recognize that 84% of severe hypoglycemia cases had a preceding episode: If hypoglycemia occurs, the regimen needs adjustment for future doses, but the current scheduled basal dose should still be given while treating the acute hypoglycemia 7

4. Beware of nocturnal hypoglycemia: Most hypoglycemia with basal insulin occurs between midnight and 6 AM 7. If this pattern emerges, consider dose reduction or switching to twice-daily dosing rather than holding doses 8, 9

Practical Parameters

Instead of holding parameters, establish treatment parameters:

• BG <70 mg/dL (<3.9 mmol/L): Treat with 15-20g glucose, continue scheduled basal insulin, monitor closely 3, 4
• BG <54 mg/dL (<3.0 mmol/L): Treat immediately, continue basal insulin, reassess total daily dose for next day 4
• Recurrent hypoglycemia: Reduce basal insulin dose by 10-20% for subsequent days, but give current scheduled dose 7

The only scenario to potentially hold Lantus would be during periods of rapidly declining renal or hepatic function where prolonged hypoglycemia risk is extremely high, but this requires physician evaluation, not a standing parameter 1.